Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 May 23:6:17.
doi: 10.1186/1471-2393-6-17.

Study protocol: a double blind placebo controlled trial examining the effect of domperidone on the composition of breast milk [NCT00308334]

Marsha L Campbell-Yeo  1 , Alexander C Allen, K S Joseph, Joyce M Ledwidge, Victoria M Allen, Kent C Dooley
Affiliations

Study protocol: a double blind placebo controlled trial examining the effect of domperidone on the composition of breast milk [NCT00308334]

Marsha L Campbell-Yeo et al. BMC Pregnancy Childbirth. .

Abstract

Background: Domperidone, a drug that enhances upper gastric motility, is an anti-dopaminergic medication that also elevates prolactin levels. It has been shown to safely increase the milk supply of lactating women. To date, researchers have analyzed the effects of domperidone on lactating woman with respect to the quantity of their milk production, adverse effects, and drug levels in the breast milk. However, the effect of domperidone on the macronutrient composition of breast milk has not been studied and current guidelines for fortification of human milk for premature infants do not distinguish between those women using or those not using domperidone. The purpose of this study is to evaluate the effect of domperidone (given to lactating mothers of very preterm infants) on the macronutrient composition of breast milk.

Methods/design: Mothers of infants delivered at less than 31 weeks gestation, who are at least 3 weeks postpartum, and experiencing lactational failure despite non-pharmacological interventions, will be randomized to receive domperidone (10 mg three times daily) or placebo for a 14-day period. Breast milk samples will be obtained the day prior to beginning treatment and on days 4, 7 and 14. The macronutrient (protein, fat, carbohydrate and energy) and macromineral content (calcium, phosphorus and sodium) will be analyzed and compared between the two groups. Additional outcome measures will include milk volumes, serum prolactin levels (measured on days 0, 4, and 10), daily infant weights and breastfeeding rates at 2 weeks post study completion and at discharge. Forty-four participants will be recruited into the study. Analysis will be carried out using the intention to treat approach.

Discussion: If domperidone causes significant changes to the nutrient content of breast milk, an alteration in feeding practices for preterm infants may need to be made in order to optimize growth, nutrition and neurodevelopment outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Allocation of Participants to the Trial Groups.
See this image and copyright information in PMC

References

    1. American Academy of Pediatrics. Work Group on Breastfeeding Breastfeeding and the use of human milk. Pediatrics. 1997;100:1035–1039. doi: 10.1542/peds.100.6.1035. - DOI - PubMed
    1. Canadian Pediatric Society clinical practice guidelines Nutrition for healthy term infants. J Paediatr Child Health. 1998;3:109–112. - PMC - PubMed
    1. Schanler RJ, Hurst NM. Human milk for the hospitalized preterm infant. Semin Perinatol. 1994;18:476–486. - PubMed
    1. Schanler RJ, Shulman RJ, Lau C. Feeding strategies for preterm infants: beneficial outcomes feeding fortified milk versus preterm formula. Pediatrics. 1999;103:1150–1157. doi: 10.1542/peds.103.6.1150. - DOI - PubMed
    1. Nutrition Committee. Canadian Paediatric Society Nutrient needs and feeding of premature infants. Can Med Assoc J. 1995;152:1765–1784. - PMC - PubMed